IDEXX LABORATORIES INC /DE (IDXX) FY2024 Annual Balance Sheet

Balance Sheet

As of 2024-12-31

Swipe to see the full flow
IDEXX LABORATORIES INC /DE (IDXX) FY2024 Annual Balance SheetBalance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.Current liabilities$1.07 BLiabilities$1.70 BNon-current liabilities$630.21 MCurrent assets$1.40 BEquity$1.60 BAssets$3.29 BGross equity(calculated)$7.02 BNon-current assets$1.89 BHOLDINGSASSET CLASSASSETSCLAIM CLASSCLAIM SUB-CLASSCLAIMSAccounts receivable, net of allowance of $12,585 in 2024 and $9,501 in 2023InventoriesCash and cash equivalentsOther current assetsProperty and equipment, netOther long-term assetsGoodwillOperating lease right-of-use assetsIntangible assets, netAccrued liabilitiesCredit facilityCurrent portion of long-term debtAccounts payableCurrent portion of deferred revenueLong-term debt, net of current portionLong-term operating lease liabilities, net of current portionOther long-term liabilitiesLong-term deferred revenue, net of current portionDeferred income tax liabilitiesRetained earningsAdditional paid-in capitalCommon stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,836 shares in 2024 and 107,506 shares in 2023; Outstanding: 81,604 shares in 2024 and 83,032 shares in 2023Deferred stock units: Outstanding: 60 units in 2024 and 59 units in 2023Current assetsNon-current assetsAssetsCurrent liabilitiesNon-current liabilitiesLiabilitiesEquityGross equity (calculated)Treasury stock, at cost: 26,232 shares in 2024 and 24,474 shares in 2023Accumulated other comprehensive lossAccrued liabilitiesAccrued liabilities$502.12 MCurrent liabilitiesCurrent liabilities$1.07 BCredit facilityCredit facility$250.00 MLiabilitiesLiabilities$1.70 BCurrent portion of long-term debtCurrent portion of long-term debt$167.79 MAccounts payableAccounts payable$114.21 MCurrent portion of deferred revenueCurrent portion of deferred revenue$33.80 MLong-term debt, net of current portionLong-term debt, net of current portion$449.79 MNon-current liabilitiesNon-current liabilities$630.21 MLong-term operating lease liabilities, net of current portionLong-term operating lease liabilities, net$97.84 MOther long-term liabilitiesOther long-term liabilities$44.34 MCurrent assetsCurrent assets$1.40 BLong-term deferred revenue, net of current portionLong-term deferred revenue, net of current portion$26.94 MAccounts receivable, net of allowance of $12,585 in 2024 and $9,501 in 2023Accounts receivable, net$473.58 MEquityEquity$1.60 BDeferred income tax liabilitiesDeferred income tax liabilities$11.31 MAssetsAssets$3.29 BInventoriesInventories$381.88 MGross equity (calculated)Gross equity(calculated)$7.02 BCash and cash equivalentsCash and cash equivalents$288.27 MOther current assetsOther current assets$256.18 MNon-current assetsNon-current assets$1.89 BProperty and equipment, netProperty and equipment, net$713.12 MOther long-term assetsOther long-term assets$547.52 MRetained earningsRetained earnings$5.33 BGoodwillGoodwill$405.10 MOperating lease right-of-use assetsOperating lease right-of-use assets$116.13 MIntangible assets, netIntangible assets, net$111.68 MAdditional paid-in capitalAdditional paid-in capital$1.67 BCommon stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,836 shares in 2024 and 107,506 shares in 2023; Outstanding: 81,604 shares in 2024 and 83,032 shares in 2023Common stock$10.78 MDeferred stock units: Outstanding: 60 units in 2024 and 59 units in 2023Deferred stock units: Outstanding:60 units in 2024 and 59 units in 2023$5.89 MTreasury stock, at cost: 26,232 shares in 2024 and 24,474 shares in 2023Treasury stock−$5.33 BAccumulated other comprehensive lossAccumulated other comprehensive loss−$93.65 M
Chart details

IDEXX LABORATORIES INC /DE (IDXX) FY2024 Annual Balance Sheet

Balance sheet as of 2024-12-31. The chart shows assets, liabilities and equity at that date.

Assets
3,293,443,000 US dollars
Current assets
1,399,897,000 US dollars
Non-current assets
1,893,546,000 US dollars
Liabilities
1,698,130,000 US dollars
Current liabilities
1,067,916,000 US dollars
Non-current liabilities
630,214,000 US dollars
Equity
1,595,313,000 US dollars
Accounts receivable, net of allowance of $12,585 in 2024 and $9,501 in 2023
473,575,000 US dollars
Inventories
381,877,000 US dollars
Cash and cash equivalents
288,266,000 US dollars
Other current assets
256,179,000 US dollars
Property and equipment, net
713,123,000 US dollars
Other long-term assets
547,518,000 US dollars
Goodwill
405,100,000 US dollars
Operating lease right-of-use assets
116,129,000 US dollars
Intangible assets, net
111,676,000 US dollars
Accrued liabilities
502,119,000 US dollars
Credit facility
250,000,000 US dollars
Current portion of long-term debt
167,787,000 US dollars
Accounts payable
114,211,000 US dollars
Current portion of deferred revenue
33,799,000 US dollars
Long-term debt, net of current portion
449,786,000 US dollars
Long-term operating lease liabilities, net of current portion
97,836,000 US dollars
Other long-term liabilities
44,341,000 US dollars
Long-term deferred revenue, net of current portion
26,939,000 US dollars
Deferred income tax liabilities
11,312,000 US dollars
Retained earnings
5,332,438,000 US dollars
Additional paid-in capital
1,673,863,000 US dollars
Common stock, $0.10 par value: Authorized: 120,000 shares; Issued: 107,836 shares in 2024 and 107,506 shares in 2023; Outstanding: 81,604 shares in 2024 and 83,032 shares in 2023
10,784,000 US dollars
Deferred stock units: Outstanding: 60 units in 2024 and 59 units in 2023
5,885,000 US dollars
Treasury stock, at cost: 26,232 shares in 2024 and 24,474 shares in 2023
negative 5,334,012,000 US dollars
Accumulated other comprehensive loss
negative 93,645,000 US dollars
Gross equity (calculated)
7,022,970,000 US dollars. Net equity plus the magnitudes of its negative contributions equals gross positive equity. The negative contributions enter this reconciliation as add-backs; their filed signs stay negative.

Chart connections

  • Assets equal liabilities plus consolidated equity. Consolidated equity includes noncontrolling interests when reported.
  • Treasury shares and other negative equity contributions reduce equity.
IDEXX LABORATORIES INC /DE (IDXX) FY2024 Annual Balance Sheet Sankey chart
Free to share unchanged, with credit to Plicit.ai · CC BY-NC-ND 4.0Download PNG

Newsletter

Get the teardowns by email

Subscribe if you want the public-company teardowns in your inbox when they're released.

Product waitlist

Health Check and Teardown for your own company

A health check uncovers insights of your private books, not a public ticker. Join this list to get notified as soon as we go-live!